SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)
$47.09 0.11 (0.2341%)
Analysed SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) News Sources
Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest
23-06-2026
yahoo.com
Strength Seen in Supernus (SUPN): Can Its 5.2% Jump Turn into More Strength?
09-07-2026
yahoo.com
Supernus Celebrates Five-Year Anniversary of Qelbree® FDA Approval, Continuing to Deliver on Real-World Experience in ADHD
14-07-2026
yahoo.com
1 Growth Stock to Stash and 2 We Turn Down
15-07-2026
yahoo.com
1 Cash-Producing Stock on Our Buy List and 2 That Underwhelm
16-07-2026
yahoo.com
Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026
22-07-2026
yahoo.com
Will Supernus (SUPN) Beat Estimates Again in Its Next Earnings Report?
27-07-2026
yahoo.com
Supernus Pharmaceuticals (SUPN) Could Be 25% Undervalued On Rising Earnings Expectations
28-07-2026
yahoo.com
Is Rising Earnings Optimism Altering The Investment Case For Supernus Pharmaceuticals (SUPN)?
28-07-2026
yahoo.com
Supernus Pharmaceuticals (SUPN) Expected to Beat Earnings Estimates: Should You Buy?
28-07-2026
yahoo.com
What is the current price of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The current price of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is $47.09.
SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) since the previous trading day is $0.11.
SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) since the previous trading day is 0.2341%.
What is the most recent average sentiment score for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The most recent average sentiment score for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)?
The most recent sentiment for SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ) is .
SEC-8K** Filing Available For SUPERNUS PHARMACEUTICALS INC (SUPN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.